Quantitative formats are no longer niche. They’re fast becoming standard in respiratory panels, chronic disease monitoring, and decentralized clinical trials. But building a quantitative lateral flow test that’s reliable, scalable, and regulator-ready is no small feat.

In this ALFC Sponsor Series episode, Klaus Hochleitner, Global Lead Technology Product Specialist for Diagnostics at Cytiva, joins DCN Dx’s Mitzi Rettinger and Pat Vaughan, Ph.D., to break down what developers get wrong—and what the best teams are doing differently. From membrane selection to reader alignment, Klaus shares hard-earned insight into the technical decisions that make or break performance.

We also preview his upcoming lunch & learn session at ALFC 2025: “Considerations in the Development of Quantitative Lateral Flow Tests.” Whether you’re deep in optimization or just scoping feasibility, this episode delivers clear, actionable guidance for developing quantitative tests that work.

Presented in partnership with Cytiva, Platinum Sponsor of the 2025 Advanced Lateral Flow Conference.